Genetic Mutation Analysis tests in Dubai & UAE

Compare available Genetic Mutation Analysis tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

800.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Mutation Analysis test prices

Showing 1–11 of 11 matching tests.

Genetic Mutation Analysis diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1875 Achondroplasia Mutation Analysis (FGFR3 Gene G1138A, G1138C) Test This test identifies the most common genetic mutations (G1138A and G1138C) in the FGFR3 gene associated with achondroplasia.	Peripheral Whole Blood (3–5 mL EDTA)	10–12 Working Days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FGFR3 gene mutations (c.1138G>A, c.1138G>C)", "Presence of specific pathogenic variants"] Parameters [] Preparation ["No fasting required"] Indications ["Clinical suspicion of achondroplasia", "Prenatal screening for achondroplasia", "Family history of achondroplasia", "Genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 91761-6 ICD-10: Q77.4 Clinical summary This test identifies the most common genetic mutations (G1138A and G1138C) in the FGFR3 gene associated with achondroplasia.
TEST-1920 AIP Genetic Test for Pituitary Adenoma (Prolactin-Secreting) This test evaluates the entire coding region of the AIP gene for germline mutations associated with hereditary pituitary adenomas.	Peripheral whole blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline mutations in the AIP gene", "Copy Number Variants (CNVs) within the AIP gene"] Parameters [] Preparation ["Mandatory genetic counselling session prior to testing", "Construct a three-generation family pedigree", "No fasting or dietary restrictions required"] Indications ["Personal history of pituitary neoplasia", "Family history of pituitary neoplasia", "Suspicion of Familial Isolated Pituitary Adenoma (FIPA)"] Measurement technique Confirm with laboratory Codes LOINC: 81696-2 ICD-10: D35.2, E22.1, Z15.89 Clinical summary This test evaluates the entire coding region of the AIP gene for germline mutations associated with hereditary pituitary adenomas.
TEST-1679 CXCR4 Gene Mutation Analysis Test This test identifies pathogenic variants in the CXCR4 gene associated with WHIM syndrome, cancer predisposition, and hematopoietic stem cell homing defects.	Peripheral Whole Blood (3 mL EDTA)	7–8 Working Days	1,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CXCR4 gene"] Parameters [{"name": "CXCR4 Gene Mutation Status", "reference_range": "Negative (No pathogenic variant detected)"}] Preparation ["6-hour fasting period required", "Valid doctor’s prescription is mandatory (except for specific cases)"] Indications ["Suspected WHIM syndrome", "Metastatic cancer predisposition", "Hematopoietic stem cell homing defects", "Pre-surgical screening", "Antenatal genetic counseling", "Official travel-abroad screening"] Measurement technique Confirm with laboratory Codes LOINC: 81229-3 ICD-10: D81.0, Z15.89, Z13.79 Clinical summary This test identifies pathogenic variants in the CXCR4 gene associated with WHIM syndrome, cancer predisposition, and hematopoietic stem cell homing defects.
TEST-1682 Cystic Fibrosis Mutation Screening (CFTR Test This test specifically identifies the presence or absence of the common CFTR ΔF508 mutation.	Peripheral blood	7–8 days	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CFTR gene mutation (ΔF508)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusions"] Indications ["Carrier screening", "Family planning", "Diagnostic confirmation in suspected cases"] Measurement technique Confirm with laboratory Codes LOINC: 21657-1 ICD-10: E84.9, Z13.228 Clinical summary This test specifically identifies the presence or absence of the common CFTR ΔF508 mutation.
TEST-3931 F5 Gene Budd-Chiari Syndrome Genetic Test This test analyzes the entire coding region of the F5 gene to detect pathogenic mutations associated with Budd-Chiari syndrome and inherited thrombophilia.	Peripheral Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the F5 gene", "Presence of known and novel variants"] Parameters [] Preparation ["No fasting required", "No medication changes required"] Indications ["Patients with Budd-Chiari syndrome", "Patients with unexplained hepatic vein thrombosis", "Patients with a negative traditional thrombophilia panel but high clinical suspicion"] Measurement technique Confirm with laboratory Codes LOINC: 21616-1 ICD-10: Z13.89 Clinical summary This test analyzes the entire coding region of the F5 gene to detect pathogenic mutations associated with Budd-Chiari syndrome and inherited thrombophilia.
TEST-4706 IL1RN Gene Mutation Analysis (DIRA) Test This test identifies mutations in the IL1RN gene, which cause Deficiency of Interleukin-1 Receptor Antagonist (DIRA).	Whole blood (EDTA) or FTA card	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IL1RN gene sequence", "Copy Number Variations (CNVs) in IL1RN gene", "Exon-intron boundaries", "5'/3' UTR regions"] Parameters [] Preparation [] Indications ["Suspected Deficiency of Interleukin-1 Receptor Antagonist (DIRA)", "Infants presenting with sterile osteomyelitis and pustular rash", "Family history suggestive of DIRA"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: D89.89 Clinical summary This test identifies mutations in the IL1RN gene, which cause Deficiency of Interleukin-1 Receptor Antagonist (DIRA).
TEST-777 JAK2 Mutation Detection (RNA) Qualitative Test This test detects the presence or absence of the JAK2 V617F mutation in RNA extracted from peripheral whole blood.	Peripheral whole blood	24 h (phone) / 36 h (email) – 3rd working day report	1,100.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["JAK2 V617F mutation (c.1849G>T) in RNA transcript"] Parameters [] Preparation ["No special preparation needed", "May eat and drink normally", "Continue prescribed medications"] Indications ["Diagnosis of Philadelphia-negative MPNs (polycythemia vera, essential thrombocythemia, primary myelofibrosis)", "Differentiation of primary vs. secondary MPNs", "Guiding treatment decisions"] Measurement technique Confirm with laboratory Codes LOINC: 36882-3 ICD-10: D47.1 Clinical summary This test detects the presence or absence of the JAK2 V617F mutation in RNA extracted from peripheral whole blood.
TEST-1373 MTHFR Gene Mutation Analysis (C677T & A1298C) Test This test evaluates the presence of the C677T and A1298C variants in the MTHFR gene.	Peripheral Whole Blood	3–4 Days	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MTHFR C677T variant", "MTHFR A1298C variant", "Folate metabolism pathway"] Parameters [{"name": "MTHFR C677T", "reference_range": "Wild-type (CC), Heterozygous (CT), Homozygous (TT)"}, {"name": "MTHFR A1298C", "reference_range": "Wild-type (AA), Heterozygous (AC), Homozygous (CC)"}] Preparation ["No fasting required", "No medication or supplement stoppage needed"] Indications ["Assessment of risk for cardiovascular disease", "Evaluation of risk for venous thromboembolism", "Investigation of recurrent pregnancy loss", "Guidance for folate supplementation"] Measurement technique Confirm with laboratory Codes LOINC: 48768-8 ICD-10: Z13.89 Clinical summary This test evaluates the presence of the C677T and A1298C variants in the MTHFR gene.
TEST-1317 MYD88 Gene Mutation Analysis Test This test identifies the presence or absence of the MYD88 L265P somatic mutation in peripheral blood.	Peripheral whole blood (EDTA tube)	5–7 working days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MYD88 L265P mutation", "Somatic gene mutation"] Parameters [{"name": "MYD88 L265P Mutation", "reference_range": "Negative / Positive"}] Preparation ["No fasting required.", "No medication adjustments required unless directed by your doctor.", "A prescription from a DHA-licensed physician is mandatory."] Indications ["Diagnosis of Waldenström macroglobulinemia", "Diagnosis of activated B-cell lymphomas", "Prognosis stratification in B-cell neoplasms", "Guidance for targeted therapy (e.g., BTK inhibitors)"] Measurement technique Confirm with laboratory Codes LOINC: 83011-4 ICD-10: C88.0, C83.30, D84.8 Clinical summary This test identifies the presence or absence of the MYD88 L265P somatic mutation in peripheral blood.
TEST-1951 NPM1 Gene Exon 11 Sequencing (NGS) Test This test identifies mutations in the NPM1 gene, specifically within exon 11, using Next Generation Sequencing.	Peripheral Whole Blood or Dried Blood Spot (FTA Card)	3–4 Weeks (expedited available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Point mutations in NPM1 gene exon 11", "Small insertions/deletions in NPM1 gene exon 11", "Variant Allele Frequency (VAF)"] Parameters [] Preparation [] Indications ["Confirmed or suspected diagnosis of AML", "Confirmed or suspected diagnosis of Myeloid Sarcoma", "Confirmed or suspected diagnosis of Clonal Cytopenia of Undetermined Significance"] Measurement technique Confirm with laboratory Codes LOINC: 94438-0 ICD-10: C92.0 Clinical summary This test identifies mutations in the NPM1 gene, specifically within exon 11, using Next Generation Sequencing.
TEST-1092 Targeted Mutation Analysis (2 Mutations) Test This test detects the presence or absence of two specific DNA sequence variants using Sanger sequencing.	Peripheral blood, plasma, serum, amniotic fluid, cord blood, chorionic villi	10–15 days from collection	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Specific DNA sequence variants", "Gene mutations"] Parameters [] Preparation ["Follow physician's advice regarding temporary pausing of certain supplements"] Indications ["Hereditary breast/ovarian cancer syndromes", "Prenatal diagnosis", "Genetic rheumatic disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81263-9 ICD-10: Z13.89 Clinical summary This test detects the presence or absence of two specific DNA sequence variants using Sanger sequencing.

Category overview

Genetic Mutation Analysis: overview

Whether navigating a family history of chronic illness or seeking clarity on complex symptoms, a detailed understanding of your DNA provides vital reassurance. As part of our Molecular Diagnostics division, our Genetic Mutation Analysis leverages cutting-edge sequencing technologies to safely and accurately map inherited molecular variations. Rather than making a definitive standalone diagnosis, this specialized genetic mutation analysis data equips your healthcare team with the essential insights needed for customized, proactive medical guidance. Renowned among premium diagnostic labs in the UAE, DNA Labs UAE promises rigorous patient confidentiality alongside incredibly fast, highly accurate results. Take control of your personalized care journey: review our genetic mutation analysis testing in the UAE below to book an appointment, arrange a seamless home sample collection, or consult our specialized team.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.